SU429813A1 - METHOD OF TREATING PULMONARY TUBERCULOSIS - Google Patents
METHOD OF TREATING PULMONARY TUBERCULOSISInfo
- Publication number
- SU429813A1 SU429813A1 SU1684551A SU1684551A SU429813A1 SU 429813 A1 SU429813 A1 SU 429813A1 SU 1684551 A SU1684551 A SU 1684551A SU 1684551 A SU1684551 A SU 1684551A SU 429813 A1 SU429813 A1 SU 429813A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- pulmonary tuberculosis
- treating pulmonary
- tuberculosis
- treating
- patients
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
II
Изобретение относитс к области медицины .This invention relates to the field of medicine.
Известно применение дл лечени туберкулеза легких туберкулостатических средств.It is known to treat pulmonary tuberculosis in treating tuberculosis.
Цель изобретени - лечение больных с норэргической и пониженной реактивностью организма.The purpose of the invention is the treatment of patients with norergic and reduced reactivity of the organism.
Дл этого одновременно с туберкулостатическими средствами примен ют этимизол.To do this, simultaneously with tuberculostatic agents, etizol is used.
Способ лечени больных туберкулезоим осуществл ют следующим образом.The method for treating patients with tuberculosis is as follows.
Одновременно с туберкулостатическими препаратами примен ют 1,57о-пый раствор этимизола в суточных дозах 60-80 мг из расчета 1 мк/кг веса больного. Препарат ввод т внутримышечно по 1-2 мл в две-три инъекции . Кроме внутримышечного введени , возможно также подкожное и внутривенное введение .препарата, а также пероральное в виде таблеток. У подростков по сравнению со взрослыми примен ют меньшие дозы - не более 3 мл 1,5%-ного препарата в двух-трехSimultaneously with tuberculostatic drugs, a 1.57% solution of aetizol is used in daily doses of 60-80 mg at a rate of 1 micron / kg of patient weight. The drug is administered intramuscularly in a dose of 1-2 ml in two or three injections. In addition to intramuscular administration, subcutaneous and intravenous administration of the preparation is also possible, as well as oral administration in the form of tablets. In adolescents, compared with adults, smaller doses are used - no more than 3 ml of 1.5% drug in two or three
инъекци х. Курс лечени этимизолом продолжают 30-50 дпей и в случае необходимости повтор ют после двух-четырехнедельного интервала .injections. The treatment with etizol is continued at 30-50 dpi and, if necessary, is repeated after a two to four week interval.
Применение этимизола в комплексной терапии больных туберкулезом существенно повышает эффективность лечени . При этом достигаетс быстра дези-нтоксикаци , абацилирование , инволюци воспалительных изменений в короткие сроки, снижение аллергической настроенности организма улучшение переносимости химпрепаратов.The use of ethymol in the complex therapy of patients with tuberculosis significantly increases the effectiveness of treatment. At the same time, quick detoxification, abacilization, involution of inflammatory changes in a short time, reduction of the body's allergic mood, improvement of tolerability of chemicals are achieved.
Предмет изобретени Subject invention
Способ лечени туберкулеза легких с помощью туберкулостатических средств, отличающийс тем, что, с целью лечени больных с норэргической и понижепной реактивностью организма, одновременно с туберкулостатическими средствами примен ют этимизол .A method of treating pulmonary tuberculosis using tuberculostatic agents, characterized in that, in order to treat patients with norergic and lower body reactivity, etizol is used simultaneously with tuberculostatic agents.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU1684551A SU429813A1 (en) | 1971-08-20 | 1971-08-20 | METHOD OF TREATING PULMONARY TUBERCULOSIS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU1684551A SU429813A1 (en) | 1971-08-20 | 1971-08-20 | METHOD OF TREATING PULMONARY TUBERCULOSIS |
Publications (1)
Publication Number | Publication Date |
---|---|
SU429813A1 true SU429813A1 (en) | 1974-05-30 |
Family
ID=20483930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU1684551A SU429813A1 (en) | 1971-08-20 | 1971-08-20 | METHOD OF TREATING PULMONARY TUBERCULOSIS |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU429813A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5422350A (en) * | 1992-09-10 | 1995-06-06 | Warner-Lambert Company | Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use |
US5466696A (en) * | 1992-09-10 | 1995-11-14 | Warner Lambert Company | Tacrine and cytochrome P450 oxidase inhibitors and methods of use |
-
1971
- 1971-08-20 SU SU1684551A patent/SU429813A1/en active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5422350A (en) * | 1992-09-10 | 1995-06-06 | Warner-Lambert Company | Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use |
US5466696A (en) * | 1992-09-10 | 1995-11-14 | Warner Lambert Company | Tacrine and cytochrome P450 oxidase inhibitors and methods of use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU95101385A (en) | Products containing g-csf and tnf-binding protein | |
Bush | Prolonged neuromuscular block due to intraperitoneal streptomycin | |
KR910005858A (en) | Fatty acid therapy | |
SU429813A1 (en) | METHOD OF TREATING PULMONARY TUBERCULOSIS | |
MY106603A (en) | Treatment of genital warts with a combination of liquid nitrogen and recombinant dna human alpha interferon | |
Verrill et al. | Vasovagal faint in the supine position. | |
Redpath et al. | The side effects of carbamazepine therapy | |
KR20000005479A (en) | New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses | |
RU95112520A (en) | APPLICATION 4'-IODO-4'-DEOXIDOXORUBICINE FOR THE TREATMENT OF AMYLOIDOSIS, METHOD OF TREATMENT OF AMYLOIDOSIS | |
RU1803119C (en) | Method of extrauterine pregnancy treatment | |
Gjessing et al. | Intramuscular injection of procaine penicillin combined with oral administration of ampicillin in the treatment of gonorrhoea | |
SU624635A1 (en) | Method of treating chronic calculus-free pancreatitis | |
SU1725902A1 (en) | Method of children treatment with chronic tonsillitis | |
Furman et al. | Use of Cholinergic Drugs in Paroxysmal Supraventricular Tachycardia: Serious Untoward Reactions and Fatality from Treatment with Methacholine and Neostigmine | |
Mukerji et al. | The treatment of intestinal worms with the indigenous drugs Butea, Embelia and kamala | |
SU1391654A1 (en) | Method of treatment of chronic gastroduodenits | |
RU2140270C1 (en) | Method of treatment of patient with kaposi's sarcoma idiopathic type | |
SU1255134A1 (en) | Method of treatment of pain syndrome in myocardial infarction | |
RU2233664C2 (en) | Method for treatment of lichen ruber planus | |
Waxman | Management of depression. | |
Gilles et al. | Treatment of intestinal parasites in children | |
RU2099061C1 (en) | Method for treating the cases of neurodermite | |
RU2071342C1 (en) | Method of treatment of cirrhotic form of lung tuberculosis | |
SU1034741A1 (en) | Tuberculosis treatment method | |
RU2108799C1 (en) | Method of treatment of nodular erythema |